MaxCyte, Inc. (MXCT) Operating cash flow 2019–2025
MaxCyte, Inc. (MXCT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$34.4MFY2025 · since FY2019: -$8.8M → -$34.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$34.4M | -24.6% |
| FY2024 | -$27.6M | -27.3% |
| FY2023 | -$21.7M | -46.7% |
| FY2022 | -$14.8M | -38.4% |
| FY2021 | -$10.7M | -21.6% |
| FY2020 | -$8.8M | +0.2% |
| FY2019 | -$8.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice